Annual Report 2019-2020 Allergy New Zealand
Total Page:16
File Type:pdf, Size:1020Kb
ALLERGY NEW ZEALAND ANNUAL REPORT 2019-2020 ALLERGY NEW ZEALAND CLICK HERE TO GO BACK TO CONTENTS Thanks to our supporters and sponsors Contents Message from the Chair 04 People in the Organisation 05 CEO Report 07 Thanks to our Supporters 13 Treasurer’s Report 14 Financial Statements 15 Auditor’s Report 28 Our Vision: a world where allergies no longer affect quality of life Our Mission: to enhance the health and well being of people living with allergies by sharing current knowledge and expertise and leading positive change through being a strong and credible national voice. 2 | Allergy New Zealand Annual Report 2019-2020 Allergy New Zealand Annual Report 2019-2020 | 3 THE TEAM It has been another huge year for our staff, volunteers and all People in the the people who come together at different times of the year and on different projects to support Allergy New Zealand. Organisation They have delivered a strong financial result in extraordinary circumstances to set Allergy New Zealand up for an exciting 2021. However a lot of our organisation’s THE BOARD OF THE NATIONAL visible presence is experienced by allergy sufferers directly TRUSTEES 2019-2020 SUPPORT NETWORK Message from from the quiet, consistent work of our national volunteer Jilesh Mistry, Chairman REGIONAL network. It has been very challenging this year to maintain COORDINATORS Dot Louie, Vice Chairperson Jilesh Mistry connections and I know Mark and his team are conscious Sue Devaliant, Northland of that. We all hope that next year the hold of the pandemic Matt Coulter, Treasurer Elizabeth Brown, the Chair lessens and eases that sense of isolation. Kristen De Monchy, Secretary Auckland West The other, often invisible, area of effort is the advocacy Kimberley Madden-Snoad, work that Penny Jorgensen tirelessly drives. Again Penny DIRECTORS: Auckland South has pulled off miracles and disappeared down rabbit holes Hemant Lad Anna Mosley, Tauranga elcome to the Annual Report of Allergy families in our allergy community – access and affordability that only she could navigate, to reappear again triumphant. Delwyn Robinson, Tauranga New Zealand for the 2020 financial year. of adrenaline auto-injectors. Covid-19 has meant Penny has had to work from home, THE MEDICAL Simone Antcliff, Tauranga W Allergy New Zealand has had a very successful If Allergy New Zealand could provide free access adopt new technologies and sustain our influence across AND SCIENTIFIC Claire Eveleigh, Wellington and eventful 12 months and I’m pleased to report that the to this life saving device, they could deliver a tangible numerous environments and platforms. Whether it is ADVISORY PANEL organisation is in good heart and improving financial health. benefit to our allergy community, while at the same time comforting a distressed allergy parent over the phone Wendi Turner, Nelson Associate Professor The 5 Year Board Strategic Plan (refer Page 6) has demonstrating how cheap and easy it would be for the or advising a meeting room of MPI executives via Zoom, Rohan Ameratunga Barbara Britten, Christchurch again established our criteria for assessing the numerous government/Pharmac to achieve, if they elected to fund she projects credibility, warmth and consistency. We are Dr Andy Baker Haley Ng, Timaru opportunities and ongoing projects that Mark and his team the EpiPen® themselves. Ie zero extra cost of distribution. tremendously lucky to enjoy her wholehearted support, Dr Shannon Brothers Wendy Jenkins, Invercargill have put up for consideration during the year. It is a key We were fortunate to secure funding of $300,000 from Pub knowledge and dedication. Pauline Brown Erin Martin, Dunedin governance document for us and has inspired us to further Charity who supported Allergy NZ to deliver on this initiative. Although Allergy NZ’s successes are always the result improve the best way we as a Board can support the strong As hoped for, it has been a game-changer. While of a large teams’ efforts, Mark and Penny are central to Jenny Heyward outcomes that our organisation continues to produce. delivering towards all 3 of our core 5 Year Strategies, it has ensuring they happen. I, on behalf of the Board would Dr Diana Purvis LIFE MEMBERS I would like to acknowledge the efforts and teamwork generated additional benefits. Mark reports in more detail like to take this opportunity to thank them for all the effort Anna Richards Carmela Maplesen of my fellow Board members who have enjoyed working on the FundaPen™ success in his CEO report, but in short: they put in to delivering on our Mission each year: Dr Richard Steele Carolyn Sutherland together despite some extraordinary times this year. We • Nearly 3,000 New Zealanders at risk of anaphylaxis ‘To enhance the health and wellbeing of people living Dr Kuang Hsaio Dan Williams welcomed Kristen just before our AGM last year and received a free EpiPen® with allergies by sharing current knowledge and expertise Dr Rebekah Wilson Dorothy Spencer she has more than delivered in her role as Secretary, • 1,100 general practices and all of NZ’s Primary Health and leading positive change through being a strong and Dr Maia Brewerton Helena & Luke Merson her experience of living with allergies and as a volunteer Organisations were made aware that FundaPen™ was credible national voice for our members’. Dr Anna Gilmour Jill MacFarlane assisting Mark and Penny with strong connections and created and coordinated by Allergy New Zealand for The Board sincerely appreciates their passion. Peter and Lisa Aish network opportunities. The Board is significantly stronger the benefit of their patients Dr Peter Storey for her contributions. • More than 100,000 hits were made to our Facebook MEMBERSHIP Margaret Wong Likewise I know that our team has benefited from page in the 48 hours following launch Research from our network of international allergy charities HONORARY Marie & Mike Gaudin Matt Coulter’s financial knowledge and broad experience • NZ’s allergy clinical networks unanimously supported inspired Mark to propose reviewing our membership model ACCOUNTANT Mark Coyle with the charity sector in New Zealand. He has provided the FundaPen™ program and urged their respective last year. I am pleased to report that since making it free Scott Browne — Browne’s Natalie Lloyd Chartered Accountants significant time and rigour to our financial governance DHBs to get involved. to join Allergy New Zealand at our AGM last year, we have Ros Campbell and his critical risk assessment of opportunities is • Despite a national measles epidemic, EpiPen® supply experienced a surge in new members and I welcome all Sandra Sheard much appreciated. issues and multiple lockdowns it only took 9 months to those who have joined over the last 12 months. HONORARY Greg and Sara-Jane Murison Also to Dot for her years of loyal service to Allergy NZ exhaust our FundaPen™ supply. The more members of the allergy community that we LAWYER in so many roles and for the significant commercial and The message to everyone involved was clear. We represent , the more compelling Allergy New Zealand can Alexandra Sharman Sue Cochrane operational experience that Hemant brings to the team. had demonstrated the size of an unmet need. We had be as a national voice for allergies. Val Gillanders Working as a team in isolation has tested all of us and demonstrated the apparent ease with which an existing So please spread the word and encourage the allergy VOLUNTEERS Penny Jorgensen despite the obvious challenges of not being able to operate health system could deliver a highly valued benefit. We community and others to join and support us to make Penny King Sir Peter Leitch as we normally would in our communities, I can report that had demonstrated that everyone involved from the public positive change happen. Isabella Murison Dr Jan Sinclair Allergy New Zealand has still managed to have a significant health system in delivering FundapPen™ understood the Allergy New Zealand needs your support to grow – to Mikayla Madden-Snoad Dr Penny Fitzharris positive impact on the quality of lives of New Zealanders need and supported it without hesitation. effect those changes! living with allergies. The next challenge for the team is to deliver that And many others who have helped in countless ways. message as an invitation to Government and Pharmac to HEAD OFFICE FUNDAPEN™ work together with us to resolve the current burden that Mark Dixon A corner stone of extending our national reach this year our allergy families carry on their own. Penny Jorgensen has been the FundaPen™ project. Mark and his team The Board is fully behind this initiative and the Jilesh Mistry Penny King presented a concept to highlight the plight of many momentum it has created. Chair, Allergy NZ CLICK HERE TO CLICK HERE TO GO BACK TO GO BACK TO CONTENTS CONTENTS 4 | Allergy New Zealand Annual Report 2019-2020 Allergy New Zealand Annual Report 2019-2020 | 5 Allergy New Zealand: Strategy to 2024 1. BEST PRACTICE MEDICAL/CLINICAL TREATMENT: OBJECTIVE: Best practice medical advice, prevention, management and MISSION treatment services are accessible to all people living in New Zealand with allergies To improve the Health Professionals Definitely undertake quality of life • Health professional education programme workshops, articles in publications, for people living handout packs, advocacy, networking with medical bodies. CEO • Monitoring of health services from a patient perspective with allergies in – advocacy and patient rights New Zealand • Establish alliances with other